Erectile Dysfunction. Disorders of male genital organs in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: Tadalafil 20 mg tablets(Farabi, Iran), one tablet daily for 4 weeks. Patients were evaluated before treatment, 4, 8, and 12 weeks after treatment by International P
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
50 Years to 70 Years
Inclusion criteria
Inclusion criteria: Known cases of diabetes with lower urinary tract symptoms and erectile dysfunction Age between 50-70 years With international prostate symptom score greater than 12 in who are treated with oral diabetes medications or insulin
Exclusion criteria
Exclusion criteria: Uncontrolled blood pressure Chronic kidney disease Liver failure Unstable coronary disease Psychiatric illness Contraindications to receiving tadalafil or tamsulosin Prostate malignancies bladder stones Retention history History of previous prostate surgery Urinary tract infection Neurogenic Bladder Treatment with finasteride in the last 6 months History of ductal stenosis History of bladder neck obstruction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erectile Dysfunction. Timepoint: Before intervention, 4, 8 and 12 weeks after intervention. Method of measurement: The International Index of Erectile Function (IIEF). | — |
Secondary
| Measure | Time frame |
|---|---|
| Lower urinary tract symptoms. Timepoint: Before intervention, 4, 8 and 12 weeks after intervention. Method of measurement: The International Prostate Symptom Score (IPSS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyyed Hossein Ghasemi
Babol University of Medical Sciences
Outcome results
None listed